Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00292-021-00918-9 http://scihub22266oqcxt.onion/10.1007/s00292-021-00918-9 33560456!7871953!33560456     free     free     free       Pathologe 2021 ; 42 (2): 164-171 Nephropedia Template TP {{tp|p=33560456|t=2021. COVID-19: Auswirkungen auf Lunge und Herz |pdf=|usr=}}{{33560456}} gab.com Text COVID-19: Auswirkungen auf Lunge und Herz JO: Pathologe http://www.kidney.de/pget.php?&tw=1&pmid=33560456 #FOAvip Viral respiratory diseases constitute the most common reasons for hospitalization with more than half of all acute illnesses worldwide. Progressive respiratory failure with pronounced diffuse alveolar damage has been identified as the primary cause of death in COVID-19. COVID-19 pneumonia shares common histopathological hallmarks with influenza (H1N1)-related ARDS, like diffuse alveolar damage (DAD) with edema, hemorrhage, and intra-alveolar fibrin deposition. The lungs with COVID-19 pneumonia revealed perivascular inflammation, an endothelial injury, microangiopathy, and an aberrant blood vessel neoformation by intussusceptive angiogenesis. While this pronounced angiocentric inflammation is likely be found - to varying degrees - in numerous other organs, e.g., the heart, COVID-19 is hypothesized to be not just a pulmonary, but rather a systemic "vascular disease." Twit Text FOAVip COVID-19: Auswirkungen auf Lunge und Herz ????Pathologe http://www.kidney.de/pget.php?&tw=1&pmid=33560456 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33560456 #FOAvip English Wikipedia <ref>{{Cite pmid|33560456}}</ref> COVID-19: Auswirkungen auf Lunge und Herz #MMPMID33560456 Ackermann M; Werlein C; Langer F; Kuhnel MP; Jonigk DD Pathologe 2021[Mar]; 42 (2): 164-171 PMID33560456show ga Viral respiratory diseases constitute the most common reasons for hospitalization with more than half of all acute illnesses worldwide. Progressive respiratory failure with pronounced diffuse alveolar damage has been identified as the primary cause of death in COVID-19. COVID-19 pneumonia shares common histopathological hallmarks with influenza (H1N1)-related ARDS, like diffuse alveolar damage (DAD) with edema, hemorrhage, and intra-alveolar fibrin deposition. The lungs with COVID-19 pneumonia revealed perivascular inflammation, an endothelial injury, microangiopathy, and an aberrant blood vessel neoformation by intussusceptive angiogenesis. While this pronounced angiocentric inflammation is likely be found - to varying degrees - in numerous other organs, e.g., the heart, COVID-19 is hypothesized to be not just a pulmonary, but rather a systemic "vascular disease." |*COVID-19[MESH] |*Influenza A Virus, H1N1 Subtype[MESH] |Heart[MESH] |Humans[MESH] |Lung[MESH]COVID-19: Auswirkungen auf Lunge und Herz (epmc).pdf DeepDyve Pubget Overpricing